T A Gooley

Summary

Affiliation: Fred Hutchinson Cancer Research Center
Country: USA

Publications

  1. ncbi Estimation of failure probabilities in the presence of competing risks: new representations of old estimators
    T A Gooley
    Fred Hutchinson Cancer Research Center, Clinical Research Division, Seattle, WA 98109 1024, USA
    Stat Med 18:695-706. 1999
  2. ncbi Allogeneic bone marrow transplantation in children with myelodysplastic syndrome or juvenile myelomonocytic leukemia: the Seattle experience
    U Yusuf
    Fred Hutchinson Cancer Research Center and University of Washington Department of Pediatrics, Seattle, WA 98109, USA
    Bone Marrow Transplant 33:805-14. 2004
  3. ncbi Outcome of allogeneic bone marrow transplantation for children with advanced acute myeloid leukemia
    E R Nemecek
    Department of Pediatrics, Clinical Research Division, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA 98109, USA
    Bone Marrow Transplant 34:799-806. 2004
  4. ncbi Imatinib therapy prior to myeloablative allogeneic stem cell transplantation
    J M Zaucha
    Department of Hematology, Medical University of Gdansk, Gdansk, Poland
    Bone Marrow Transplant 36:417-24. 2005

Detail Information

Publications4

  1. ncbi Estimation of failure probabilities in the presence of competing risks: new representations of old estimators
    T A Gooley
    Fred Hutchinson Cancer Research Center, Clinical Research Division, Seattle, WA 98109 1024, USA
    Stat Med 18:695-706. 1999
    ....
  2. ncbi Allogeneic bone marrow transplantation in children with myelodysplastic syndrome or juvenile myelomonocytic leukemia: the Seattle experience
    U Yusuf
    Fred Hutchinson Cancer Research Center and University of Washington Department of Pediatrics, Seattle, WA 98109, USA
    Bone Marrow Transplant 33:805-14. 2004
    ..5 times more likely to relapse (P=0.01). The median follow-up among the 43 surviving patients is 10 years (range 1-25). We conclude that allogeneic BMT for children with MDS is well tolerated and can be curative...
  3. ncbi Outcome of allogeneic bone marrow transplantation for children with advanced acute myeloid leukemia
    E R Nemecek
    Department of Pediatrics, Clinical Research Division, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA 98109, USA
    Bone Marrow Transplant 34:799-806. 2004
    ..Survival for children transplanted in CR2 or untreated first relapse is higher than that previously reported, but relapse remains the major cause of treatment failure regardless of disease stage...
  4. ncbi Imatinib therapy prior to myeloablative allogeneic stem cell transplantation
    J M Zaucha
    Department of Hematology, Medical University of Gdansk, Gdansk, Poland
    Bone Marrow Transplant 36:417-24. 2005
    ..65, P = 0.60). These data do not provide any evidence that imatinib preceding HSCT increases acute transplant-related toxicities...